Knockdown of TRIM21 inhibits ferroptosis via the p62-Keap1-Nrf2 pathway thereby improving brain injury and mitochondrial dysfunction after ischemia-reperfusion in mice
Clicks: 7
ID: 321629
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
7 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #13 of 40 articles by views in Journal of Neuropathology & Experimental Neurology
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Ferroptosis has a crucial role in cerebral ischemia-reperfusion injury (IRI) but its potential modulation is a key challenge in the treatment of ischemic stroke. The function and mechanism of the E3 ubiquitin ligase tripartite motif-containing protein 21 (TRIM21) in neurological diseases, particularly its regulatory role in ferroptosis are unclear. We used a mouse model of transient middle cerebral artery occlusion (tMCAO/R) and a PC12 cell model of oxygen-glucose deprivation/reperfusion (OGD/R) to investigate the effects of virus-mediated gene knockdown of TRIM21. Effects were assessed using Western blotting, immunoprecipitation, biochemical assays, and behavioral tests. TRIM21 expression was significantly increased after cerebral IRI. Knockdown of TRIM21 improved neurological deficits, reduced cerebral infarct size, and suppressed inflammation. Knockdown of TRIM21 also inhibited ferroptosis and improved mitochondrial function whereas TRIM21 negatively regulated the p62-Keap1-Nrf2 pathway through ubiquitination of p62. Salvage experiments confirmed that Nrf2 is a key downstream molecule for the neuroprotective effects of TRIM21. The data indicate that TRIM21 inhibition of the Keap1-Nrf2 pathway through p62 ubiquitination exacerbated ferroptosis after ischemic stroke in the tMCAO/R model and suggest that targeted inhibition of TRIM21 holds promise as a novel strategy for treating ischemic stroke.
| Reference Key |
openalex_W7169753625
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Bo Yang, Yanxia Sun, Yao Zhang, Yanli Gu, Zheng Liu |
| Journal | Journal of Neuropathology & Experimental Neurology |
| Year | 2026 |
| DOI |
10.1093/jnen/nlag075
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.